On the other hand, reduction in HDAC2 expression and activity leads to enhanced inflammation and reduced steroid responsiveness in chronic obstructive pulmonary disease (COPD) [73]. The gene discussed is HDAC2; the disease is chronic obstructive pulmonary disease.